🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchOrforglipron ATTAIN-4 — my results so far Page 4

Orforglipron ATTAIN-4 — my results so far

roxy_nash Sat, Jul 12, 2025 at 6:46 AM 43 replies 2,076 viewsPage 4 of 9
PharmacoVig_BOS
Senior Member
1,567
8,901
Feb 2024
Boston, MA
Jul 25, 2025 at 10:57 AM#16

Clinical perspective, offered as context rather than as advice. If two explanations both fit, the useful question is which one predicts something the other does not. That is answerable; arguing about which sounds more plausible is not.

Last edited: Jul 25, 2025 at 1:57 PM
14 12amsterdam_pete, LondonLisa, mike_nyc and 11 others
Reply Quote Save Share Report
CryptoCarl
Member
789
3,456
May 2024
Arizona
Jul 27, 2025 at 1:49 PM#17
Dr.AddMedPHL said:
Worth stating the units and the reference range whenever you post a number here.

Coming at Dr.AddMedPHL’s question from a different direction. Take it one variable at a time. Almost every unanswerable question in these threads is unanswerable because three things changed in the same fortnight, and no amount of subsequent argument can untangle them after the fact.

15 13MariaRD, AussieAnna, BethLabQueen and 12 others
Reply Quote Save Share Report
Dr.PathRoch
Member
456
2,123
Jun 2024
Rochester, MN
Jul 29, 2025 at 4:42 PM#18

The figures, for anyone assembling their own picture. If you are going to change something, change one thing and give it long enough to express itself. Four weeks is the usual minimum for anything pharmacological on this board, and two weeks of data has told you almost nothing.

16 14WendyG_ATL, SaraMom3, Dr.MetabolicMD and 13 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
TomFromTexas
Member
645
2,890
May 2024
Austin, TX
Jul 31, 2025 at 7:36 PM#19

A narrower follow-up, since the general answer is now clear:

What did you change at the same time, and can you separate the two now?

Last edited: Jul 31, 2025 at 9:36 PM
17 15PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 14 others
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
Aug 2, 2025 at 10:31 PM#20

Moderator note: two posts asking for a source have been merged into one. Please search the thread before asking again. Carry on.

39 12PurityPaulOR, MaxMetOK, MounjBrad and 36 others
Reply Quote Save Share Report

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register